BridgeMD
New treatment option for End Stage Renal Disease (ESRD)
Official title Impact of APP-assisted Patient Management on the Quality Control of Blood Purification Therapy
ClinicalTrials.gov ID: NCT07291154
What this study is testing
- What it's testing
- Many maintenance hemodialysis (MHD) patients develop negative outlooks due to their illnesses and complications, making their quality of life and prognosis a clinical concern. Effective life management and treatment cooperation are crucial to improving dialysis quality and patient outcomes.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- Patients with stage 5 chronic kidney disease, who have received maintenance hemodialysis for more than 3 months, are aged between 18 and 75 years...
- Patients with relatively stable condition, who are able to take care of themselves and willing to cooperate with the study.
- Patients who can understand and proficiently use WeChat and the "Yueya" mini - program used in this study.
You likely can't join if
- Patients with communication barriers or other conditions that prevent them from cooperating with the study.
- Patients who have a history of acute myocardial infarction, cerebral infarction or intracerebral hemorrhage in the past six months.
- Patients who are not willing to actively cooperate with the study.
- Patients with severe liver cirrhosis, active tuberculosis and AIDS.
The study team makes the final eligibility decision.
Where it's taking place
- Chongqing, Chongqing Municipality, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chongqing, Chongqing Municipality, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.